Intraoperative Hypotension and Metabolomics in Major Upper Gastrointestinal Surgery
NCT ID: NCT05828862
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
85 participants
INTERVENTIONAL
2023-04-22
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypotension Prediction Index in Major Gastrointestinal Surgery
NCT04966364
HPI in Older Patients Undergoing Major Gastrointestinal Surgery
NCT05297318
The Association Between Intraoperative Hypotension and Perioperative Stroke
NCT04117867
Ability of Hypotension Prediction Index to Predict Hypotension Events in Thoracic Surgery
NCT05117151
Arterial Waveform Analysis for Predicting Post-induction Hypotension
NCT05756933
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Postoperative ileus (POI) generally defines absence of flatus within 72 hours after surgery. POI is known as the most important factor to slow patient recovery, increase postoperative morbidity and prolong the hospital stay following major upper abdominal surgery. Metabolomics can investigate the small molecule changes in response to certain stimulus, such as different environments. Metabolomics involves the comprehensive analysis of metabolites. In recent years, metabolomics has several applications in the early diagnosis and prevention of health and disease. However, the association between the POI occurrence and the metabolites in the presence and absence HPI guidance have not yet been investigated.
The proposed strategy and specific objectives of this 2 years project using a randomized controlled trial are as the follows:
1. To clarify the relationship of POI occurrence to presence and absence of HPI guidance
2. To Explore differences in metabolites in presence or absence of HPI guidance.
3. Explore the potential metabolites associated with POI in different intraoperative environment in using HPI and no HPI guidance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hypotension prediction index guided
patients with hypotension prediction index guidance
hypotension prediction index guidance
using hypotension prediction index guidance to prevent intraoperative hypotension
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hypotension prediction index guidance
using hypotension prediction index guidance to prevent intraoperative hypotension
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Chih-Jun Lai, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202301110DIND
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.